Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival

Breast Cancer Research and Treatment

Volumn 129, Issue 1, 2011, Pages 235-245

  Varadi, Verena ^a   Bevier, Melanie ^a   Grzybowska, Ewa ^b   Johansson, Robert ^c   Enquist, Kerstin ^c   Henriksson, Roger ^c,d   Butkiewicz, Dorota ^b   Pamula Pilat, Jolanta ^b   Tecza, Karolina ^b   Hemminki, Kari ^a,e   Lenner, Per ^c   Försti, Asta ^a,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c UMEÅ UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Chromosomal instability; Polymerases; Prognostic marker; SNPs

Indexed keywords

DNA DIRECTED DNA POLYMERASE BETA; DNA DIRECTED DNA POLYMERASE DELTA; DNA DIRECTED DNA POLYMERASE THETA; DNA DIRECTED DNA POLYMERASE ZETA; DNA POLYMERASE; DNA POLYMERASE REV1; PROTEIN MAD2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA POLYMERASE BETA GENE; DNA POLYMERASE DELTA GENE; DNA POLYMERASE THETA GENE; DNA POLYMERASE ZETA GENE; ENZYME ACTIVE SITE; ETHNIC GROUP; EVENT FREE SURVIVAL; FAMILY HISTORY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAD2L2 GENE; MAJOR CLINICAL STUDY; MALE; POLISH; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REV1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDISH; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA-BINDING PROTEINS; DNA-DIRECTED DNA POLYMERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK; SURVIVAL ANALYSIS; SWEDEN; YOUNG ADULT;

EID: 79960845296     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1460-z     Document Type: Article

References (26)

1. KW Caldecott 2008 Single-strand break repair and genetic disease Nat Rev Genet 9 8 619 631 18626472 1:CAS:528:DC%2BD1cXpsVOku7Y%3D
2. EC Friedberg 2005 Suffering in silence: the tolerance of DNA damage Nat Rev Mol Cell Biol 6 12 943 953 16341080 10.1038/nrm1781 1:CAS:528: DC%2BD2MXht1ykurnO (Pubitemid 41778713)
3. LA Loeb RJ Monnat Jr 2008 DNA polymerases and human disease Nat Rev Genet 9 8 594 604 18626473 10.1038/nrg2345 1:CAS:528:DC%2BD1cXpsVOku7g%3D
4. JB Sweasy JM Lauper KA Eckert 2006 DNA polymerases and human diseases Radiat Res 166 5 693 714 17067213 10.1667/RR0706.1 1:CAS:528:DC%2BD28XhtFygsLzK (Pubitemid 44706607)
5. U Hubscher G Maga S Spadari 2002 Eukaryotic DNA polymerases Annu Rev Biochem 71 133 163 12045093 10.1146/annurev.biochem.71.090501.150041 1:CAS:528:DC%2BD38Xos1Clsbk%3D (Pubitemid 34800217)
6. JP Wittschieben SC Reshmi SM Gollin RD Wood 2006 Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells Cancer Res 66 1 134 142 16397225 10.1158/0008-5472.CAN-05-2982 1:CAS:528:DC%2BD28XhsFWitA%3D%3D (Pubitemid 43166018)
7. MR Albertella A Lau MJ O'Connor 2005 The overexpression of specialized DNA polymerases in cancer DNA Repair (Amst) 4 5 583 593 10.1016/j.dnarep.2005. 01.005 1:CAS:528:DC%2BD2MXivFyru7s%3D (Pubitemid 40462046)
8. JM Brondello MJ Pillaire C Rodriguez PA Gourraud J Selves C Cazaux J Piette 2008 Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta Oncogene 27 47 6093 6101 18622427 10.1038/onc.2008.212 1:CAS:528:DC%2BD1cXht1Cms7rK
9. SL Carter AC Eklund IS Kohane LN Harris Z Szallasi 2006 A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers Nat Genet 38 9 1043 1048 16921376 10.1038/ng1861 1:CAS:528:DC%2BD28XovVWjtr0%3D (Pubitemid 44325930)
10. JK Habermann J Doering S Hautaniemi UJ Roblick NK Bundgen D Nicorici U Kronenwett S Rathnagiriswaran RK Mettu Y Ma S Kruger HP Bruch G Auer NL Guo T Ried 2009 The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome Int J Cancer 124 7 1552 1564 19101988 10.1002/ijc.24017 1:CAS:528:DC%2BD1MXivVarsr8%3D
11. H Rajagopalan C Lengauer 2004 Aneuploidy and cancer Nature 432 7015 338 341 15549096 10.1038/nature03099 1:CAS:528:DC%2BD2cXpvVCjtLY%3D (Pubitemid 39551662)
12. K Kawamura R Bahar M Seimiya M Chiyo A Wada S Okada M Hatano T Tokuhisa H Kimura S Watanabe I Honda S Sakiyama M Tagawa J OW 2004 DNA polymerase theta is preferentially expressed in lymphoid tissues and upregulated in human cancers Int J Cancer 109 1 9 16 14735462 10.1002/ijc.11666 1:CAS:528: DC%2BD2cXhs1SmtLs%3D (Pubitemid 38160656)
13. DK Srivastava I Husain CL Arteaga SH Wilson 1999 DNA polymerase beta expression differences in selected human tumors and cell lines Carcinogenesis 20 6 1049 1054 10357787 10.1093/carcin/20.6.1049 1:CAS:528:DyaK1MXjvVKjt74%3D (Pubitemid 29263750)
14. D Szuts AP Marcus M Himoto S Iwai JE Sale 2008 REV1 restrains DNA polymerase zeta to ensure frame fidelity during translesion synthesis of UV photoproducts in vivo Nucleic Acids Res 36 21 6767 6780 18953031 10.1093/nar/gkn651
15. R Kaaks E Lundin S Rinaldi J Manjer C Biessy S Soderberg P Lenner L Janzon E Riboli G Berglund G Hallmans 2002 Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden Cancer Causes Control 13 4 307 316 12074500 10.1023/A:1015270324325 (Pubitemid 34553511)
16. A Brendle A Brandt R Johansson K Enquist G Hallmans K Hemminki P Lenner A Forsti 2009 Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study Eur J Cancer 45 3 435 442 19008095 10.1016/j.ejca.2008.10.001 1:CAS:528:DC%2BD1MXhs1CnsLk%3D
17. V Varadi A Brendle A Brandt R Johansson K Enquist R Henriksson U Svenson B Tavelin G Roos K Hemminki P Lenner A Forsti 2009 Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis Eur J Cancer 45 17 3008 3016 19766477 10.1016/j.ejca.2009.08.012 1:CAS:528: DC%2BD1MXhtlyjsbbI
18. A Vaclavicek JL Bermejo B Wappenschmidt A Meindl C Sutter RK Schmutzler M Kiechle P Bugert B Burwinkel CR Bartram K Hemminki A Forsti 2007 Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk Breast Cancer Res Treat 106 2 205 213 17268814 10.1007/s10549-007- 9496-9 1:CAS:528:DC%2BD2sXht1Cgt7fJ (Pubitemid 350045019)
19. PC Ng S Henikoff 2003 SIFT: predicting amino acid changes that affect protein function Nucleic Acids Res 31 13 3812 3814 12824425 10.1093/nar/gkg509 1:CAS:528:DC%2BD3sXltVWjs7s%3D (Pubitemid 37442253)
20. PC Ng S Henikoff 2001 Predicting deleterious amino acid substitutions Genome Res 11 5 863 874 11337480 10.1101/gr.176601 1:CAS:528: DC%2BD3MXjs1Wmu7w%3D (Pubitemid 32447869)
21. JC Barrett B Fry J Maller MJ Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263 265 15297300 10.1093/bioinformatics/bth457 1:CAS:528:DC%2BD2MXkt1WitQ%3D%3D (Pubitemid 40202029)
22. S Negrini VG Gorgoulis TD Halazonetis 2010 Genomic instability-an evolving hallmark of cancer Nat Rev Mol Cell Biol 11 3 220 228 20177397 10.1038/nrm2858 1:CAS:528:DC%2BC3cXitlaisb4%3D
23. CZ Bachrati ID Hickson 2003 RecQ helicases: suppressors of tumorigenesis and premature aging Biochem J 374 Pt 3 577 606 12803543 10.1042/BJ20030491 1:CAS:528:DC%2BD3sXntFamsb0%3D (Pubitemid 37163904)
24. RD Kennedy AD D'Andrea 2006 DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes J Clin Oncol 24 23 3799 3808 16896009 10.1200/JCO.2005.05.4171 1:CAS:528:DC%2BD28XpsVaqsLw%3D (Pubitemid 46622318)
25. T Ripperger D Gadzicki A Meindl B Schlegelberger 2009 Breast cancer susceptibility: current knowledge and implications for genetic counselling Eur J Hum Genet 17 6 722 731 19092773 10.1038/ejhg.2008.212 1:CAS:528: DC%2BD1MXmtFKnsLg%3D
26. J Han C Haiman T Niu Q Guo DG Cox WC Willett SE Hankinson DJ Hunter 2009 Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk Breast Cancer Res Treat 115 3 613 622 18551366 10.1007/s10549-008-0089-z 1:CAS:528:DC%2BD1MXmsVCrtbo%3D